Mirogabalin efficacy and safety for chemotherapy-induced peripheral neuropathy: single-centre retrospective observational study
Treatment with an effective dose of mirogabalin suggests an improvement in CIPN induced by various neurotoxic chemotherapeutic agents regardless of whether chemotherapy was ongoing or completed.
Authors
- Ryo Yokoyama
- Masahiro Hirakawa (ORCID: https://orcid.org/0000-0002-2145-3522)
- Kohichi Takada (ORCID: https://orcid.org/0000-0002-1393-9442)
- Hirofumi Ohnishi (ORCID: https://orcid.org/0000-0002-5873-6438)
- Norito Suzuki
- Soshi Iwasaki (ORCID: https://orcid.org/0000-0001-5681-3922)
- Yutaka Okagawa (ORCID: https://orcid.org/0000-0002-1215-1901)
- Makoto Yoshida (ORCID: https://orcid.org/0000-0001-8013-9712)
- Kazuyuki Murase (ORCID: https://orcid.org/0000-0003-2642-8665)
- Masahide Yamazaki
- Tomohiro Kubo
Institutions
- Sapporo Medical University (JP)
- Sapporo Medical University Hospital (JP)
Publication Details
- Journal
- BMJ Supportive & Palliative Care
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1136/spcare-2025-005814
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00